CNC Centene Corporation

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces an Investigation of Centene Corp. and Advises Investors with Losses to Contact the Firm

Lundin Law PC (http://lundinlawpc.com/) announces that it is investigating claims against Centene Corp. (“Centene” or the “Company”) (NYSE: CNC) concerning possible violations of federal securities laws.

To get more information about this investigation, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via email at [email protected].

The investigation centers on statements made after Centene’s acquisition of Health Net, Inc. on March 24, 2016. In the months after the acquisition, the Company told investors that there were no negative developments in the Health Net medical reserves. On July 26, 2016, Centene announced that it increased reserves for medical claims associated with disputed costs for substance abuse treatment centers and that it recorded “premium deficiency reserves primarily associated with Arizona and the California individual PPO business.” When this information was released, Centene shares fell in value.

Lundin Law PC was created by Brian Lundin, a securities litigator based in Los Angeles.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

EN
09/09/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Centene Corporation

Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: September 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: August 16, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Centene Corp: 1 director

Two Directors at Centene Corp bought 19,512 shares at between 0.000USD and 25.500USD. The significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: August 2, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ResearchPool Subscriptions

Get the most out of your insights

Get in touch